DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:


SEARCH JOBS






Collaborations

ACADIA Pharmaceuticals, Inc.  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Cubist Pharmaceuticals, Inc. 





 Company News
Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients With Schizophrenia Compared to Seroquel XR® (quetiapine XR) 5/21/2013 10:51:38 AM    More...
Sunovion Pharmaceuticals Inc. Presents Results From a One-year, Large Simple Safety Study of BROVANA® (arformoterol tartrate) Inhalation Solution 5/20/2013 10:23:33 AM    More...
Sunovion Pharmaceuticals Inc. to Present Three Posters on Results of One-year Large Simple Safety Study for BROVANA® (arformoterol tartrate) Inhalation Solution at 2013 American Thoracic Society International Conference 5/16/2013 10:05:52 AM    More...
Sunovion Pharmaceuticals Inc. Selects BioPharm Systems, Inc. 's Siebel Clinical Trial Management System Accelerator to Facilitate Fully Outsourced Clinical Trial Management Model 3/29/2013 9:53:28 AM    More...
Sunovion Pharmaceuticals Inc. Announces FDA Acceptance for Review of New Drug Application Resubmission for STEDESA® (eslicarbazepine acetate) as a Once-Daily Adjunctive Therapy for Partial-onset Seizures in Adults With Epilepsy 2/27/2013 11:02:15 AM    More...
Sunovion Pharmaceuticals Inc. to Close Down Operations Along With 32 Local Jobs 12/6/2012 7:40:41 AM    More...
Sunovion Pharmaceuticals Inc. Presents New Clinical Safety Data From the Pediatric Development Program for ZETONNA® (ciclesonide) Nasal Aerosol at American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting 11/12/2012 9:55:49 AM    More...
PsychoGenics Inc. Achieves Substantial Milestone in Its Drug Discovery Collaboration With Sunovion Pharmaceuticals Inc. 11/5/2012 9:49:18 AM    More...
Sunovion Pharmaceuticals Inc. Announces FDA Acceptance of 2 sNDAs for Latuda® as Monotherapy and Adjunctive Therapy in Adult Patients With Depressive Episodes Associated with Bipolar I Disorder 10/30/2012 7:07:13 AM    More...
Sunovion Pharmaceuticals Inc. Files Two Supplemental New Drug Applications Seeking Approval for the Use of Latuda® (lurasidone HCl) as Monotherapy and Adjunctive Therapy in Adult Patients With Depressive Episodes Associated With Bipolar I Disorder 9/6/2012 9:59:44 AM    More...
12345678910...